Active Biotech AB publ announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced operating loss was SEK 12.6 million compared to SEK 10.1 million a year ago. Net loss was SEK 12.6 million compared to SEK 9.8 million a year ago. Basic loss per share from continuing operations was SEK 0.06 compared to SEK 0.06 a year ago. For the half year, operating loss was SEK 22.4 million compared to SEK 19.9 million a year ago. Net loss was SEK 22.4 million compared to SEK 19.9 million a year ago. Basic loss per share from continuing operations was SEK 0.11 compared to SEK 0.12 a year ago.